Rosopatamab MMAE (HUJ-591 MMAE) is an ADC consisting of a PSMA-directed antibody (humanized IgG1 monoclonal antibody against PSMA and monomethylauristatin E (MMAE) for prostate cancer research.
Purity:
95.32%
Target:
ADC Antibody|||PSMA
* VAT and and shipping costs not included. Errors and price changes excepted
